Improvement of secondary prevention of acute coronary syndrome

Abstract

Regular usage and correct administration of secondary prevention drugs for acute coronary syndrome increase the quality of life and survival by up to 80%. This study was conducted to assess the effect of pharmacist educational intervention in improving the adherence of the physicians to guideline-recommended secondary intervention therapy for secondary prevention of acute coronary syndrome and evaluate the clinical benefit of this intervention. A prospective interventional study was conducted in Iraq, Al-Muthanna Governorate, Al-Hussein Teaching Hospital during the period from October 2021 to March 2022. A convenient sampling method was adapted to enrol the participants in the current study which included two groups including the intervention and control group. In the intervention group, the researcher sought to use an educational program, mediated by clinical pharmacists, to improve physician adherence to secondary prevention of acute coronary syndrome in hospitalized patients at discharge. There was no significant difference between the study groups at the first visit after discharge regarding the prescription of aspirin, ACEI, B blocker, or clopidogrel/ticagrelor while there was a significant difference at the end of follow up.